Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
1.
Int J Toxicol ; 38(6): 493-500, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31451011

RESUMEN

Trimethyltin (TMT) is widely used as a plastic heat stabilizer and can cause severe toxicity. Here, the effects of TMT on testosterone production by adult Leydig cells and the related mechanisms of action were investigated. Eighteen adult male Sprague Dawley rats (56 days old) were randomly divided into 3 groups and given intraperitoneal injection of TMT for 21 consecutive days at the doses of 0 (vehicle control), 5, or 10 mg/kg/d. After treatment, trunk blood was collected for hormonal analysis. In addition, related gene and protein expression in testes was detected. At 10 mg/kg, TMT significantly reduced serum testosterone levels but increased serum luteinizing and follicle-stimulating hormone levels. The messenger RNA and protein levels of luteinizing hormone/chorionic gonadotropin receptor, steroidogenic acute regulatory protein, cytochrome P450 17-hydroxylase/17,20-lyase, follicle-stimulating hormone receptor, and SRY box 9 were significantly lower in the TMT-treated testes than in controls. Immunohistochemical study showed that TMT decreased adult Leydig cell number. In conclusion, these findings indicate that TMT reduced adult Leydig cell testosterone production in vivo by directly downregulating the expression of steroidogenic enzymes and decreasing adult Leydig cell number in the testis.


Asunto(s)
Células Intersticiales del Testículo/efectos de los fármacos , Testosterona/biosíntesis , Compuestos de Trimetilestaño/farmacología , Animales , Peso Corporal/efectos de los fármacos , Regulación hacia Abajo/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Inyecciones Intraperitoneales , Células Intersticiales del Testículo/metabolismo , Masculino , Tamaño de los Órganos/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Células de Sertoli/metabolismo , Testículo/efectos de los fármacos , Testosterona/sangre , Compuestos de Trimetilestaño/administración & dosificación
2.
Neuro Endocrinol Lett ; 37(Suppl1): 111-117, 2016 Dec 18.
Artículo en Inglés | MEDLINE | ID: mdl-28263538

RESUMEN

OBJECTIVES: Extensive effort has been made to identify early markers of neurodegeneration as late stages have no chance of treatment. Recently, many experimental models have been used to study hallmarks of neuronal injury. One of them is the model of trimethyltin (TMT)-induced damage associated with cognitive decline, thus called a model of Alzheimer-like disease. OBJECTIVE AND METHODS: Our aim was to study neuronal transmission in hippocampal slices of male Wistar rats affected with a single dose of TMT (7.5 mg/kg, i.p.) during the first three weeks of its action. The monitored time periods after TMT administration were days 1-3; 8-10 and 15-17. At the same time periods, right hippocampi were collected for determination of changes in specific activities of two lysosomal enzymes. Electrophysiological measurements were based on stimulation of Schäffer collaterals and registration of evoked responses in the stratum pyramidale and the stratum radiatum at the CA3-CA1 synapse. Specific activities of N-acetyl-ß-D-glucosaminidase (NAGA) and cathepsin D (Cat D) were determined spectrophotometrically. RESULTS: During three weeks after i.p. TMT administration to rats, we found a time-dependent reduction of postsynaptic neuronal firing, expressed by diminished population spike (PoS) amplitude recorded in the stratum pyramidale accompanied with marked increase in specific activity of NAGA to respective 111%, 163% and 252% in the 1st, 2nd and 3rd week compared to unaffected rats. In the stratum radiatum, reduction of the slope of excitatory postsynaptic potential was not time-dependent but almost constantly reduced from the 1st to 3rd week after TMT administration (55-60%) compared to control rats. Specific activity of lysosomal enzyme Cat D was significantly increased in the 3rd week after TMT administration. CONCLUSION: This work demonstrates a time-dependent reduction of somatic response in the hippocampus of TMT affected rats during the first three weeks. This reduction of neuronal firing was later accompanied with increase of specific activity of NAGA and Cat D, supporting evidence that lysosomal dysfunction may be one of the primary contributors to TMT-induced neurodegeneration.


Asunto(s)
Hipocampo/enzimología , Lisosomas/enzimología , Enfermedades Neurodegenerativas/enzimología , Compuestos de Trimetilestaño/farmacología , Animales , Modelos Animales de Enfermedad , Potenciales Evocados , Hipocampo/efectos de los fármacos , Hipocampo/fisiopatología , Lisosomas/efectos de los fármacos , Masculino , Enfermedades Neurodegenerativas/inducido químicamente , Enfermedades Neurodegenerativas/fisiopatología , Neuronas/fisiología , Ratas , Ratas Wistar , Compuestos de Trimetilestaño/administración & dosificación
3.
Int J Mol Sci ; 14(8): 16817-35, 2013 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-23955266

RESUMEN

Trimethyltin (TMT) is an organotin compound exhibiting neurotoxicant effects selectively localized in the limbic system and especially marked in the hippocampus, in both experimental animal models and accidentally exposed humans. TMT administration causes selective neuronal death involving either the granular neurons of the dentate gyrus or the pyramidal cells of the Cornu Ammonis, with a different pattern of localization depending on the different species studied or the dosage schedule. TMT is broadly used to realize experimental models of hippocampal neurodegeneration associated with cognitive impairment and temporal lobe epilepsy, though the molecular mechanisms underlying the associated selective neuronal death are still not conclusively clarified. Experimental evidence indicates that TMT-induced neurodegeneration is a complex event involving different pathogenetic mechanisms, probably acting differently in animal and cell models, which include neuroinflammation, intracellular calcium overload, and oxidative stress. Microarray-based, genome-wide expression analysis has been used to investigate the molecular scenario occurring in the TMT-injured brain in different in vivo and in vitro models, producing an overwhelming amount of data. The aim of this review is to discuss and rationalize the state-of-the-art on TMT-associated genome wide expression profiles in order to identify comparable and reproducible data that may allow focusing on significantly involved pathways.


Asunto(s)
Perfilación de la Expresión Génica , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Enfermedades Neurodegenerativas/metabolismo , Compuestos de Trimetilestaño/administración & dosificación , Animales , Línea Celular , Ratones , Mitocondrias/efectos de los fármacos , Modelos Animales , Enfermedades Neurodegenerativas/inducido químicamente , Enfermedades Neurodegenerativas/genética , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Neuropéptidos/efectos de los fármacos , Neurotoxinas/administración & dosificación , Estrés Oxidativo/efectos de los fármacos , Ratas
4.
Ir J Med Sci ; 185(1): 75-84, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25638225

RESUMEN

BACKGROUND: Trimethyltin (TMT) acts as a potent neurotoxic compound especially for the hippocampus. The effects of valproic acid (VPA) on TMT-induced learning and memory deficits were investigated. METHODS: The rats were divided into: (1) control, (2) TMT, (3) TMT-VPA 1, (4) TMT-VPA 5, (5) TMT-VPA 10. TMT was injected as a single dose (12 mg/kg, ip) in groups 2-5. The animals of groups 3-5 were treated by 1, 5, and 10 mg/kg of VPA for 2 weeks. Learning and memory deficits were assessed by Morris water maze (MWM) and passive avoidance (PA) tests. The markers of oxidative stress mainly malondialdehyde (MDA) level and total thiol content were measured in the brain regions. RESULTS: In MWM test, escape latency and traveled path in the TMT group were higher than control (p < 0.05 and p < 0.01). Treatment by 1, 5, and 10 mg/kg of VPA reduced escape latency and traveled path (p < 0.01-p < 0.001). In PA test, the time latency to enter the dark compartment in TMT group was lower than control group (p < 0.01). Treatment by 5 and 10 mg/kg of VPA increased the time latency (p < 0.05-p < 0.001). MDA concentration in hippocampal tissues of TMT group was higher while, total thiol content was lower than control ones (p < 0.05). Pretreatment with 10 mg/kg of VPA decreased the MDA level while, increased total thiol content (p < 0.01). CONCLUSIONS: The results of present study showed that VPA attenuates TMT-induced memory deficits. Protective effects against brain tissues oxidative damage might have a role in the beneficial effects of VPA.


Asunto(s)
Hipocampo/efectos de los fármacos , Aprendizaje/efectos de los fármacos , Compuestos de Trimetilestaño/efectos adversos , Ácido Valproico/farmacología , Animales , Encéfalo/efectos de los fármacos , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Distribución Aleatoria , Ratas , Compuestos de Trimetilestaño/administración & dosificación
5.
Toxicol Sci ; 64(1): 83-9, 2001 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11606804

RESUMEN

In evaluating mechanisms of trimethyltin (TMT)-initiated neuronal damage, the present study focused on involvement of reactive oxygen species, protein kinase C (PKC), and glutamate receptors. Exposure of cerebellar granule cells to TMT (0.01-0.1 microM) produced primarily apoptosis, but higher concentrations were associated with cellular lactate dehydrogenase efflux and necrosis. TMT increased generation of cellular reactive oxygen species, which was inhibited by either L-NAME (inhibitor of nitric oxide synthase, NOS) or catalase, indicating that both NO and H(2)O(2) are formed on TMT exposure. Since chelerythrine (selective PKC inhibitor) also inhibited oxidative species generation, PKC appears to play a significant role in TMT-induced oxidative stress. The metabotropic glutamate receptor antagonist, MCPG, (but not MK-801) prevented oxidative species generation, indicating significant involvement of metabotropic receptors (but not NMDA receptors) in TMT-induced oxidative stress. NOS involvement in the action of TMT was confirmed through measurement of nitrite, which increased concentration dependently. Nitrite accumulation was blocked by L-NAME, chelerythrine, or MCPG, showing that NO is generated by TMT and that associated changes in NOS are regulated by a PKC-mediated mechanism. Oxidative damage by TMT was demonstrated by detection of elevated malondialdehyde levels. It was concluded that low concentrations of TMT (0.01-0.1 microM) cause apoptotic cell death in which oxidative signaling is an important event. Higher concentrations of TMT initiate necrotic death, which involves both an oxidative and a non-oxidative component. TMT-induced necrosis but not apoptosis in granule cells is mediated by glutamate receptors.


Asunto(s)
Apoptosis/efectos de los fármacos , Cerebelo/efectos de los fármacos , Necrosis , Neuronas/efectos de los fármacos , Compuestos de Trimetilestaño/toxicidad , Alcaloides , Animales , Apoptosis/fisiología , Benzofenantridinas , Catalasa/farmacología , Células Cultivadas , Cerebelo/citología , Cerebelo/metabolismo , Maleato de Dizocilpina/farmacología , Inhibidores Enzimáticos/farmacología , Antagonistas de Aminoácidos Excitadores/farmacología , Etiquetado Corte-Fin in Situ , L-Lactato Deshidrogenasa/metabolismo , NG-Nitroarginina Metil Éster/farmacología , Neuronas/citología , Neuronas/metabolismo , Nitritos/metabolismo , Fenantridinas/farmacología , Proteína Quinasa C/antagonistas & inhibidores , Proteína Quinasa C/metabolismo , Ratas , Especies Reactivas de Oxígeno/metabolismo , Receptores de Glutamato/metabolismo , Acetato de Tetradecanoilforbol/farmacología , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Compuestos de Trimetilestaño/administración & dosificación
6.
Neurosci Lett ; 47(2): 99-106, 1984 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-6462539

RESUMEN

Adult male hooded rats were tested pretreatment for spontaneous alternation and open-field behaviors. Animals were then intubated with either 5 or 7 mg/kg trimethyltin chloride (TMT Cl) or the isotonic saline vehicle. Post-treatment, animals were again tested for spontaneous alternation and open-field behaviors during three separate 5-day periods: days 14-18, days 56-60 and days 106-110. Additionally, both body weight and water intake were assessed. The larger dose of TMT Cl resulted in significant, but temporary reduction in body weight, elevated water intake for approximately 3 weeks, and a persistent increase in open-field activity. The smaller dose of TMT Cl resulted in elevated water intake for approximately 3 weeks and a temporary increase in open-field activity. Since the tendency to enter choice arms decreased in all groups across testing sessions, the effects of TMT Cl on spontaneous alternation could not be accurately assessed.


Asunto(s)
Conducta Animal/efectos de los fármacos , Actividad Motora/efectos de los fármacos , Compuestos de Trialquiltina/farmacología , Compuestos de Trimetilestaño/farmacología , Animales , Peso Corporal/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ingestión de Líquidos/efectos de los fármacos , Hipocampo/efectos de los fármacos , Masculino , Ratas , Tiempo de Reacción/efectos de los fármacos , Factores de Tiempo , Compuestos de Trimetilestaño/administración & dosificación
7.
Neurotoxicology ; 15(3): 651-4, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-7854602

RESUMEN

Groups of 12 male and 12 female rats were fed diets containing 0 or 8ppm trimethyltin chloride for up to 25 days. All the animals were observed prior to the study start and daily throughout the study for any changes in clinical condition. In addition, detailed clinical observations, including quantitative assessments of landing foot splay, sensory perception, muscle weakness and locomotor activity were monitored during the study. At the end of the study, the rats were killed and subjected to a full Post-mortem. Selected nervous system tissues were removed, processed and examined microscopically. Clinical signs typical of trimethyltin neurotoxicity (e.g. aggression, shaking and convulsions) were seen in rats receiving diets containing 8ppm trimethyltin chloride for as little as 22 days. Neuropathological lesions consisting of extensive neuronal cell necrosis in the limbic region of the brain, vacuolar degeneration of ventral horn cells of the spinal cord and a marginal increase in Wallerian-type degeneration were seen. The study demonstrates that trimethyltin neurotoxicity can be induced by dietary administration and that both male and female rats are equally sensitive.


Asunto(s)
Sistema Nervioso/efectos de los fármacos , Compuestos de Trimetilestaño/toxicidad , Animales , Peso Corporal/efectos de los fármacos , Dieta , Femenino , Masculino , Actividad Motora/efectos de los fármacos , Sistema Nervioso/patología , Ratas , Ratas Wistar , Compuestos de Trimetilestaño/administración & dosificación
8.
Neurotoxicology ; 19(1): 163-6, 1998 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9498232

RESUMEN

The temporal increase of plasma corticosterone (CORT) levels at 3 or 4 days after a single oral administration of trimethyltin (TMT) was suppressed by intracerebroventricular administration of the interleukin-1 receptor antagonist (IL-1ra). On the other hand, glutamate receptor antagonist (MK801) did not affect the TMT-induced CORT level increase. These results indicate that this transient activation of the hypothalamo-pituitary-adrenocortical axis in TMT-treated rats may be in part attributable to the neuroendocrine effects of IL-1 produced by microglia.


Asunto(s)
Corticosterona/antagonistas & inhibidores , Corticosterona/sangre , Hipocampo/efectos de los fármacos , Hipocampo/patología , Receptores de Interleucina-1/antagonistas & inhibidores , Sialoglicoproteínas/administración & dosificación , Compuestos de Trimetilestaño/toxicidad , Administración Oral , Animales , Maleato de Dizocilpina/administración & dosificación , Maleato de Dizocilpina/farmacología , Hipocampo/metabolismo , Inyecciones Intraperitoneales , Inyecciones Intraventriculares , Proteína Antagonista del Receptor de Interleucina 1 , Masculino , Necrosis , Ratas , Ratas Sprague-Dawley , Compuestos de Trimetilestaño/administración & dosificación
9.
Neurotoxicology ; 18(3): 633-43, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9339813

RESUMEN

Proper structuring of neural connections in the hippocampus is mediated by cell adhesion molecules, membrane-linked proteins involved in cell recognition and stabilization of cytoarchitecture. Modulated expression of the neural cell adhesion molecule (NCAM) at the synapse permits plasticity required for both learning and memory. Polysialylation of NCAM, particularly the synapse-specific 180 kDa isoform (NCAM180), allows hippocampal neurons to alter their neuronal connections during learning acquisition and memory consolidation in mature brain. These activity-dependent changes in NCAM expression represent a sensitive target for neurotoxicity. Trimethyltin (TMT), a potent hippocampal neurotoxicant, alters total NCAM expression in whole mouse hippocampus and impairs learning in rodents. To investigate the expression of polysialylated NCAM following TMT administration, Swiss-Webster mice were injected (i.p.) with 2.0 or 3.0 mg TMT/kg and sacrificed 6 hrs to 7 days later. Immunocytochemical staining for polysialylated NCAM (PSA-NCAM) revealed marked reduction of staining of hippocampal dentate granule cells 6-72 hours after TMT treatment. Partial recovery of hippocampal polysialylated NCAM was observed after 7 days. Immunoblot data indicated that loss of PSA-NCAM expression paralleled reductions seen in NCAM180 and markers of cytoskeletal integrity. Assays for proteolytic activity in hippocampus revealed rapid, reversible protease activation which correlated temporally with the reduction of NCAM180 and PSA-NCAM. Proteolytic degradation following hippocampal injury may serve to disrupt NCAM-mediated adhesion. Protracted loss of polysialylated NCAM in dentate gyrus following injury may serve as a useful marker in toxicant-induced learning disorders.


Asunto(s)
Hipocampo/efectos de los fármacos , Molécula L1 de Adhesión de Célula Nerviosa , Moléculas de Adhesión de Célula Nerviosa/metabolismo , Neurotoxinas/toxicidad , Ácidos Siálicos/metabolismo , Compuestos de Trimetilestaño/toxicidad , Animales , Femenino , Hipocampo/metabolismo , Inmunohistoquímica , Ratones , Neurotoxinas/administración & dosificación , Compuestos de Trimetilestaño/administración & dosificación
10.
Neurotoxicology ; 13(3): 679-700, 1992.
Artículo en Inglés | MEDLINE | ID: mdl-1475067

RESUMEN

We have demonstrated a deficit in working memory and/or consolidation of information in working memory into reference memory by a single oral dose of the neurotoxin trimethyltin(TMT). Moreover, TMT causes loss of hippocampal corticosterone receptors and increases brain glial fibrillary acidic protein(GFAP), an index of the astrocytic reaction to diverse types of CNS lesions. We tried to block the TMT-induced cognitive deficit and these biochemical markers by treating rats with purified mixed gangliosides (GS) for 21 days, starting 2 days before the TMT treatment. As expected, TMT decreased the number of corticosterone receptors in hippocampi and increased the GFAP concentration in hippocampi and to a lesser extent, in frontal cortices, measured more than 8 mon after treatment. The small increase in GFAP in frontal cortices was attenuated by GS but not in hippocampi. The pronounced learning deficits caused by TMT were attenuated to a small extent by GS in the TMT-GS group, when a learning criterion was used for the last session's performance of acquired lever-directed behavior. GS also delayed the appearance of significant performance differences between Controls and TMT-treated rats, when probed with a progressive fixed ratio schedule of reinforcement. However, most measures of learning and performance indicated that GS did not block the dysfunctional consequences of TMT treatment but instead caused similar functional decrements in rats treated with water instead of TMT. Corticosterone receptors in hippocampi were reduced to about 65% of Controls in the TMT-Water, TMT-GS, and Water-GS groups. A reduction in corticosterone receptors in hippocampi after TMT treatment probably reflects the loss of one or more cell types (e.g., pyramidal cells), which is supported by the increase in GFAP in this region. However, we did not observe a reciprocal relation between steroid receptors and GFAP after GS alone, indicating that GS did not cause detectable cell loss or cell damage, measured in this manner. Thus, reactive gliosis probably was not a pre-condition for the cognitive dysfunction. The fact that the cognitive deficits are probably related to hippocampal dysfunction supports the notion of a causal relationship between corticosterone receptor reduction and/or their altered function and cognitive impairment of this special type. The possibility that our results demonstrate potential neurobehavioral toxicity of GS is discussed in light of many reports which present data that can be similarly interpreted.


Asunto(s)
Encéfalo/efectos de los fármacos , Condicionamiento Operante/efectos de los fármacos , Gangliósidos/farmacología , Receptores de Esteroides , Compuestos de Trimetilestaño/toxicidad , Animales , Encéfalo/anatomía & histología , Corticosterona , Gangliósidos/administración & dosificación , Gangliósidos/toxicidad , Proteína Ácida Fibrilar de la Glía/análisis , Habituación Psicofisiológica/efectos de los fármacos , Hipocampo/metabolismo , Bombas de Infusión Implantables , Masculino , Morfina/farmacología , Proteínas del Tejido Nervioso/análisis , Proteínas del Tejido Nervioso/efectos de los fármacos , Tamaño de los Órganos/efectos de los fármacos , Ratas , Receptores de Glucocorticoides/efectos de los fármacos , Esquema de Refuerzo , Compuestos de Trimetilestaño/administración & dosificación , Compuestos de Trimetilestaño/antagonistas & inhibidores
11.
Toxicol Lett ; 95(1): 41-6, 1998 Mar 16.
Artículo en Inglés | MEDLINE | ID: mdl-9650645

RESUMEN

Sixteen week old male AKR/J, Balb/cByJ, C57B1/6J and DBA/2J mice received single i.p. injections of trimethyltin (TMT). The toxic effects were weight loss, hyperexcitability, tremor, clonic-tonic convulsion, posterior paresis and death. The minimum toxic dose was 1.8 mg/kg, for the AKR strain and 2.3 mg/kg for the other strains. The highest non-lethal dose was 2.7 mg/kg for the AKR, DBA/2 and C57B1/6 strains and 3.0 mg/kg for the Balb/c strain. Blood levels of TMT peaked within 1 h and declined with half-lives of approximately 1.5 days. Blood levels of TMT were lower in the C57B1/6 mice due to greater tissue binding of TMT in C57B1/6 mice. Some of the toxic endpoints showed different rank orders among the strains, leading us to conclude that more than one biological process is responsible for the acute toxic effects of TMT in mice.


Asunto(s)
Conducta Animal/efectos de los fármacos , Convulsiones/inducido químicamente , Compuestos de Trimetilestaño/farmacocinética , Compuestos de Trimetilestaño/toxicidad , Animales , Relación Dosis-Respuesta a Droga , Semivida , Inyecciones Intraperitoneales , Masculino , Ratones , Ratones Endogámicos , Paresia/inducido químicamente , Especificidad de la Especie , Temblor/inducido químicamente , Compuestos de Trimetilestaño/administración & dosificación , Pérdida de Peso/efectos de los fármacos
12.
Hear Res ; 91(1-2): 101-9, 1995 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8647712

RESUMEN

The neurotoxicant, trimethyltin (TMT) produces cochlear impairment at far lower dose levels and far more rapidly than it does central nervous system effects. The initial effects of TMT in the cochlea, in vivo, are consistent with disruption of the inner hair cell type-1 spiral ganglion cell synapse although it is uncertain whether the effect is on presynaptic and/or postsynaptic units. This synapse is believed to be an excitatory glutamatergic one, providing the possibility that TMT could induce an excitotoxic process resulting in elevations in intracellular calcium ([Ca2+]i). The objective of this study was to determine whether TMT had direct toxic effects on the postsynaptic spiral ganglion cells studied in primary culture and to identify the role of extracellular calcium in such an effect. The marker of interest was the effect of this agent on [Ca2+]i levels as determined using quantitation of the fluorescent calcium dye, Fura-2. TMT did induce a marked and sustained elevation in [Ca2+]i level in the spiral ganglion cells that appeared to have a rapid initial phase and a slower saturating phase. Studies performed using calcium-free medium showed that elevation of [Ca2+]i in spiral ganglion cells by TMT was attenuated but not entirely blocked. Further, the L-type calcium channel blocker, nifedipine, was able to inhibit the initial increase in [Ca2+]i, suggesting that at least this phase of the TMT effect was mediated by calcium channels, although nifedipine had no significant effect on the time to reach the maximal [Ca2+]i level. Parallel control experiments performed using application of exogenous glutamate and depolarizing K+ concentrations also produced elevation in [Ca2+]i levels. The data indicate that TMT elevates [Ca2+]i in isolated spiral ganglion cells both by increasing extracellular uptake via Ca2+ channels and also by releasing Ca2+ from intracellular stores. Thus TMT ototoxicity appears to include a direct postsynaptic toxic event.


Asunto(s)
Calcio/metabolismo , Ganglio Espiral de la Cóclea/efectos de los fármacos , Compuestos de Trimetilestaño/toxicidad , Análisis de Varianza , Animales , Bloqueadores de los Canales de Calcio/farmacología , Canales de Calcio/efectos de los fármacos , Células Cultivadas , Relación Dosis-Respuesta a Droga , Colorantes Fluorescentes , Fura-2/química , Cobayas , Nifedipino/farmacología , Potasio/metabolismo , Ganglio Espiral de la Cóclea/citología , Ganglio Espiral de la Cóclea/metabolismo , Compuestos de Trimetilestaño/administración & dosificación
13.
Arch Otolaryngol Head Neck Surg ; 127(5): 530-3, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11346428

RESUMEN

OBJECTIVE: To investigate the tolerability of N-chlorotaurine, a new antimicrobial agent, by application to the middle ear in a mouse model. METHODS: Five BALB/c mice were each injected through the tympanic membrane with 5 microL of 0.1%, 1.0%, and 10% N-chlorotaurine and compared with animals in which 0.9% isotonic sodium chloride solution, 0.2% gentamicin sulfate, and 0.25% trimethyltin chloride were instilled. Auditory brainstem responses to clicks were evaluated repeatedly between 4 and 75 days after injection, and histologic investigations of the inner ear were performed subsequently. Three additional groups of mice were injected with isotonic sodium chloride solution, 1.0% N-chlorotaurine, and 0.25% trimethyltin, and brainstem responses to tone bursts of 8, 16, and 32 kHz were tested. In addition, the middle ear was examined histologically. RESULTS: Mice treated with isotonic sodium chloride solution, 0.1% N-chlorotaurine, and 0.2% gentamicin sulfate did not show changes in response threshold. Treatment with 1.0% and 10% N-chlorotaurine caused a reversible increase in auditory brainstem response threshold by 20 dB 4 days after application because of local irritation around the perforation of the tympanic membrane. In contrast, 0.25% trimethyltin showed a permanent elevation of auditory brainstem response threshold of 10 to 15 dB and a scattered loss of outer hair cells predominantly in the apical turn. No alterations of the inner ear were observed in the other treatment groups. The mucous membrane of the middle ear remained unaffected in all test groups. CONCLUSION: Application of N-chlorotaurine to the middle ear is well tolerated without adverse effects and may be a useful new endogenous antimicrobial agent for local treatment of otologic infections.


Asunto(s)
Antiinfecciosos/farmacocinética , Taurina/análogos & derivados , Taurina/farmacología , Animales , Antiinfecciosos/administración & dosificación , Tolerancia a Medicamentos , Oído Interno/efectos de los fármacos , Oído Medio , Potenciales Evocados Auditivos del Tronco Encefálico/efectos de los fármacos , Gentamicinas/administración & dosificación , Gentamicinas/farmacología , Inyecciones , Masculino , Ratones , Ratones Endogámicos BALB C , Cloruro de Sodio/administración & dosificación , Cloruro de Sodio/farmacología , Taurina/administración & dosificación , Compuestos de Trimetilestaño/administración & dosificación , Compuestos de Trimetilestaño/farmacología
14.
Neurotoxicol Teratol ; 18(1): 99-111, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-8700049

RESUMEN

Previous research has explored the adverse effects of trimethyltin (TMT) on learning and memory in laboratory animals. Virtually all studies of TMT effects on learning have not, however, included appropriate controls to establish a selective effect on learning. This experiment investigated the effects of TMT on the repeated acquisition (learning) and performance of response sequences. Adult male Long-Evans rats, maintained at 300 g b.wt., were trained with food reinforcement under a multiple repeated acquisition (RA) and performance (P) schedule. The RA component required rats to learn a different three-member response sequence during each session (Center Right Left, RLC, RCL, LCR, or LRC); the correct response sequence remained constant in the P component (CLR). RA and P components alternated twice during a session. Rats were given 0, 4, or 8 mg/kg TMT IV after 30 sessions of stable baseline performance, and an additional 40 sessions were conducted following TMT. Prior to TMT, all groups maintained comparable accuracy levels in both RA and P components. Following TMT, significant decreases in both accuracy and response rate were obtained in the 8 mg/kg group. Thereafter, response rate and accuracy both recovered to near baseline levels, although large individual differences were observed. No selective effects of TMT were obtained on RA when compared to P. These data suggest that TMT-induced impairments on learning may be due to a generalized performance decrement rather than a specific effect on learning.


Asunto(s)
Condicionamiento Operante/efectos de los fármacos , Discapacidades para el Aprendizaje/inducido químicamente , Desempeño Psicomotor/efectos de los fármacos , Compuestos de Trimetilestaño/toxicidad , Animales , Proteína Ácida Fibrilar de la Glía/metabolismo , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Infusiones Intravenosas , Discapacidades para el Aprendizaje/psicología , Masculino , Ratas , Esquema de Refuerzo , Compuestos de Trimetilestaño/administración & dosificación
15.
J Pharmacol Sci ; 109(1): 60-70, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19122368

RESUMEN

The organotin trimethyltin (TMT) is known to cause neuronal degeneration in the central nervous system. A systemic injection of TMT produced neuronal damage in the cerebral frontal cortex of mice. To elucidate the mechanism(s) underlying the toxicity of TMT toward neurons, we prepared primary cultures of neurons from the cerebral cortex of mouse embryos for use in this study. Microscopic observations revealed that a continuous exposure to TMT produced neuronal damage with nuclear condensation in an incubation time-dependent manner up to 48 h. The neuronal damage induced by TMT was not blocked by N-methyl-D-aspartate receptor channel-blocker MK-801. The exposure to TMT produced an elevation of the phosphorylation level of c-Jun N-terminal kinase (JNK)(p46), but not JNK(p54), prior to neuronal death. Under the same conditions, a significant elevation was seen in the phosphorylation level of stress-activated protein kinase 1, which activates JNKs. Furthermore, TMT enhanced the expression and phosphorylation of c-Jun during a continuous exposure. The JNK inhibitor SP600125 was effective in significantly but only partially attenuating the TMT-induced nuclear condensation and accumulation of lactate dehydrogenase in the culture medium. Taken together, our data suggest that the neuronal damage induced by TMT was independent of excitotoxicity but that at least some of it was dependent on the JNK cascades in primary cultures of cortical neurons.


Asunto(s)
Proteínas Quinasas JNK Activadas por Mitógenos/metabolismo , Degeneración Nerviosa/fisiopatología , Neuronas/efectos de los fármacos , Compuestos de Trimetilestaño/toxicidad , Animales , Antracenos/administración & dosificación , Antracenos/farmacología , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Corteza Cerebral/citología , Maleato de Dizocilpina/administración & dosificación , Maleato de Dizocilpina/farmacología , Activación Enzimática/efectos de los fármacos , Fungicidas Industriales/administración & dosificación , Fungicidas Industriales/toxicidad , Immunoblotting , Inyecciones Intraperitoneales , MAP Quinasa Quinasa 4/metabolismo , Masculino , Ratones , Ratones Endogámicos , N-Metilaspartato/administración & dosificación , N-Metilaspartato/farmacología , Degeneración Nerviosa/inducido químicamente , Neuronas/citología , Neuronas/metabolismo , Fosforilación/efectos de los fármacos , Factores de Tiempo , Compuestos de Trimetilestaño/administración & dosificación
16.
Nutr Res ; 28(9): 629-34, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19083469

RESUMEN

Rutin is a flavonoid with various biological activities that are beneficial to human health. Trimethyltin is a toxic organotin compound, and rats injected with trimethyltin serve as a useful in vivo model for studying spatial memory impairment and neurodegeneration in the hippocampus. The protective effect of rutin against the trimethyltin-induced spatial memory impairment and hippocampal neuron damage in rats was examined. Peroral administration of a single dose of trimethyltin (8.5 mg/kg) induced spatial memory loss and the extensive loss of CA3 pyramidal neurons in hippocampi, as indicated by the results of a Morris water maze task and histologic examination, respectively. Prolonged supplementation of rutin significantly reversed the trimethyltin-induced spatial memory impairment and the damage to pyramidal neurons in the hippocampal CA3b region, indicating an antioxidative effect of rutin. These results suggest that rutin in the diet may provide a protective effect against spatial memory impairment accompanied by hippocampal pyramidal neuron loss.


Asunto(s)
Trastornos de la Memoria/prevención & control , Rutina/administración & dosificación , Compuestos de Trimetilestaño/administración & dosificación , Animales , Hipocampo/efectos de los fármacos , Hipocampo/patología , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Trastornos de la Memoria/inducido químicamente , Trastornos de la Memoria/patología , Tamaño de los Órganos , Células Piramidales/efectos de los fármacos , Células Piramidales/patología , Ratas , Ratas Sprague-Dawley
17.
Brain Res Bull ; 77(1): 19-26, 2008 Sep 05.
Artículo en Inglés | MEDLINE | ID: mdl-18639741

RESUMEN

Interleukin-1beta (IL-1beta) has been implicated in various neuropathologies, while IL-1 receptor antagonist (IL-1ra) has been shown to reduce neuronal injury. We investigated the pattern of expression of both cytokines in murine hippocampus after trimethyltin (TMT) intoxication. Using a ribonuclease protection assay, we demonstrated induction of transcription of IL-1beta and IL-1ra 3 days following TMT treatment which correlated with the peak of neuronal apoptosis. At this time, immunocytochemical staining revealed enhanced expression of both cytokines in NG2 proteoglycan expressing ameboid cells located at the site of neurotoxic insult, some of which bound also the microglial marker, lectin. There was some overlap between NG2 and lectin staining. Our results suggest that the two cytokines are involved in apoptotic processes in dentate granule cells and indicate that the pro-apoptotic effect of IL-1beta prevails over the presumed protective action of IL-1ra. The novel finding of expression of both cytokines in NG2(+) cells of ameboid phenotype indicates that these cells, through the regulatory roles of pro- and anti-inflammatory cytokines, may be involved in control of neuronal death or survival after injury.


Asunto(s)
Antígenos/metabolismo , Apoptosis/efectos de los fármacos , Proteína Antagonista del Receptor de Interleucina 1/genética , Interleucina-1beta/genética , Neuronas/efectos de los fármacos , Proteoglicanos/metabolismo , Compuestos de Trimetilestaño/toxicidad , Animales , Antígenos/análisis , Antígenos/biosíntesis , Bisbenzimidazol/química , Proteínas Portadoras/efectos de los fármacos , Giro Dentado/citología , Electroforesis en Gel de Poliacrilamida , Femenino , Expresión Génica/efectos de los fármacos , Hipocampo/citología , Inmunohistoquímica , Inyecciones Intraperitoneales , Proteína Antagonista del Receptor de Interleucina 1/metabolismo , Interleucina-1beta/metabolismo , Ratones , Ratones Endogámicos BALB C , Microscopía Fluorescente , Neuronas/citología , Neuronas/metabolismo , Proteoglicanos/análisis , Proteoglicanos/biosíntesis , Factores de Tiempo , Compuestos de Trimetilestaño/administración & dosificación
18.
Occup Med (Lond) ; 52(4): 227-30, 2002 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12091590

RESUMEN

Trimethyl tin chloride (TMTC) is a highly toxic organotin compound that affects four main target organs: the brain, liver, immune system and skin. Exposure can occur by inhalation, ingestion or direct skin absorption. Trimethyl tin is but one of many hazardous substances with potentially serious health consequences to which individuals working in research laboratories may be exposed. We report a preventable case of TMTC exposure. Better understanding of the Canadian Workplace Hazardous Materials Information System (WHMIS) legislation and its applicability to the research laboratory situation would prevent such unnecessary exposure to hazardous substances.


Asunto(s)
Exposición a Riesgos Ambientales/prevención & control , Compuestos de Trimetilestaño/efectos adversos , Adulto , Humanos , Laboratorios/normas , Masculino , Investigación , Estudiantes , Compuestos de Trimetilestaño/administración & dosificación
19.
Ecotoxicol Environ Saf ; 26(3): 293-301, 1993 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7507820

RESUMEN

The effects of single and repeated doses of trimethyltin (TMT) treatment on the central nervous system (CNS) of the marmoset were investigated. For the acute-dose experiment adult animals were administered 3 mg/kg of TMT chloride (ip) and were then observed for changes in behavior. Within 24 hr postinjection all animals developed tremors, ataxia, and unresponsiveness. Half of the animals had severe clinical deterioration and died at 2 to 3 days following treatment. Surviving marmosets were sacrificed and the brain was subsequently perfusion-fixed for light microscopic examination. Neuronal degeneration was observed in many cells of the Ammon's horn and fascia dentata of the hippocampus. For the chronic-dose experiment, adult marmosets received (ip) weekly doses of 0.75 mg/kg of TMT chloride for 24 weeks. No evident clinical signs or behavioral changes were observed in any of the treated animals. Histological examination revealed neuropathological changes comparatively similar but less severe than those observed in the acute-treated animals. The differences in toxicity effects between acute and chronic TMT administration are compared and discussed.


Asunto(s)
Discinesia Inducida por Medicamentos/patología , Hipocampo/patología , Compuestos de Trimetilestaño/toxicidad , Animales , Callithrix , Masculino , Necrosis/inducido químicamente , Neuronas/efectos de los fármacos , Neuronas/patología , Compuestos de Trimetilestaño/administración & dosificación
20.
Neurobehav Toxicol Teratol ; 8(6): 637-41, 1986.
Artículo en Inglés | MEDLINE | ID: mdl-2880305

RESUMEN

Changes in spontaneous activity in various regions of mouse hippocampal slices were observed following iontophoretic application of trimethyltin (TMT). TMT (0.5 mM) dissolved in 0.15 M NaCl and ejected in 30 sec periods from four barrel micropipettes using anodal ejection currents (3-28 nA) produced dose dependent increases in the spontaneous activity of 67.6% of the 34 dentate gyrus cells tested. Seventy percent of the 25 CA3 cells tested displayed prolonged (30-200 sec) decreases in activity. The majority of CA1 and CA2 cells examined also displayed a decrease in firing rate. Repeated applications of TMT produced increased variability in spontaneous firing rates in all regions tested. When slices were maintained in a low Ca++, high Co++ perfusion fluid to inhibit synaptic activity, the TMT induced increase of dentate gyrus cell firing rate was not observed. The results demonstrate that direct application of TMT produces immediate changes in hippocampal cell activity that is specific for certain regions. Significant increases in firing rate were only observed in the dentate gyrus and these effects were calcium dependent.


Asunto(s)
Hipocampo/fisiología , Compuestos de Trialquiltina/toxicidad , Compuestos de Trimetilestaño/toxicidad , Potenciales de Acción/efectos de los fármacos , Animales , Glutamatos/farmacología , Ácido Glutámico , Hipocampo/efectos de los fármacos , Técnicas In Vitro , Iontoforesis , Masculino , Ratones , Ratones Endogámicos , Sodio/farmacología , Compuestos de Trimetilestaño/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA